These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique. Stepanian S; Patel M; Porter J Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395 [TBL] [Abstract][Full Text] [Related]
4. Robotic retroperitoneal lymph node dissection for paratesticular rhabdomyosarcoma in adolescents: a case series. Clark CN; Smith J; Fuchs ME; Ching CB; DaJusta DG J Robot Surg; 2023 Dec; 17(6):3045-3048. PubMed ID: 37971637 [TBL] [Abstract][Full Text] [Related]
5. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer. Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors]. Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998 [TBL] [Abstract][Full Text] [Related]
7. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients. Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090 [TBL] [Abstract][Full Text] [Related]
8. A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissections. Lloyd P; Hong A; Furrer MA; Lee EWY; Dev HS; Coret MH; Adshead JM; Baldwin P; Knight R; Shamash J; Alifrangis C; Stoneham S; Mazhar D; Wong H; Warren A; Tran B; Lawrentschuk N; Neal DE; Thomas BC World J Urol; 2022 Jan; 40(1):119-126. PubMed ID: 34599350 [TBL] [Abstract][Full Text] [Related]
9. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour. Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110 [TBL] [Abstract][Full Text] [Related]
10. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective. Rassweiler JJ; Scheitlin W; Heidenreich A; Laguna MP; Janetschek G Eur Urol; 2008 Nov; 54(5):1004-15. PubMed ID: 18722704 [TBL] [Abstract][Full Text] [Related]
11. Postchemotherapy robotic retroperitoneal lymph node dissection for non-seminomatous germ cell tumors in the lateral decubitus position: oncological and functional outcomes. Kordan Y; Köseoğlu E; Esen B; Özkan A; Kiremit MC; Kılıç M; Esen T World J Urol; 2023 Apr; 41(4):1101-1107. PubMed ID: 36806014 [TBL] [Abstract][Full Text] [Related]